ArticleMolecular therapy oncolytics2017

Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates.

Kevin A Cassady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.